This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bièche, I. Articles by Lidereau, R. Search for Related Content PubMed PubMed Citation Articles by Bièche, I. Articles by Lidereau, R.

Increased Level of Exon 12 Alternatively Spliced BRCA2 Transcripts in Tumor Breast Tissue Compared with Normal Tissue¹

Laboratoire d’Oncogénétique, Centre René Huguenin, F-92211 St-Cloud [I. B., R. L.]; and Laboratoire de Génétique Moléculaire, Faculté des Sciences Pharmaceutiques et Biologiques de Paris, F-75006 Paris [I. B.], France

The breast cancer susceptibility gene BRCA2 is expressed in a wide range of tissues as an 11-kb mRNA transcript encoding a 3418-amino acid protein, which is involved in the response to DNA damage. To obtain a better molecular characterization of BRCA2 expression in breast tissue, we analyzed full-length BRCA2 mRNA by means of reverse transcriptase-PCR with a panel of primer pairs encompassing the entire cDNA sequence. We report the identification of an exon 12 alternatively spliced BRCA2 transcript (12-BRCA2) in normal human breast tissue, in a wide variety of other normal human tissues, and in several mouse tissues. The deletion observed in this transcript (96 bp) preserves the open reading frame, and translation of the transcript would result in a BRCA2 isoform lacking 32 amino acids between codons 2280 and 2311. The analysis of matched normal and primary tumor breast tissues from 12 patients showed that the expression level of the 12-BRCA2 transcript was higher in 4 of 12 (33%) tumor tissues compared with their normal breast tissues. Overproduction of the 12-BRCA2 variant was associated with steroid receptor-negative tumors (P = 0.0005). These data suggest that the mechanisms generating the BRCA2 mRNA variant exist in normal breast tissue and may be dysregulated in steroid receptor-negative breast tumor tissues.

This article has been cited by other articles:

				P. M. Machado, B. M. Cavaco, R. Brandao, J. Eugenio, S. Santos, A. Opiniao, and F. Vaz In Reply J. Clin. Oncol., November 1, 2007; 25(31): 5036 - 5038. [Full Text] [PDF]

				M.-N. Lee, R.-C. Tseng, H.-S. Hsu, J.-Y. Chen, C. Tzao, W. L. Ho, and Y.-C. Wang Epigenetic Inactivation of the Chromosomal Stability Control Genes BRCA1, BRCA2, and XRCC5 in Non-Small Cell Lung Cancer Clin. Cancer Res., February 1, 2007; 13(3): 832 - 838. [Abstract] [Full Text] [PDF]

				R. Huang, Z. Xing, Z. Luan, T. Wu, X. Wu, and G. Hu A Specific Splicing Variant of SVH, a Novel Human Armadillo Repeat Protein, Is Up-Regulated in Hepatocellular Carcinomas Cancer Res., July 1, 2003; 63(13): 3775 - 3782. [Abstract] [Full Text] [PDF]